Emcure, Sanofi tie up for anti-diabetic range

New Delhi: Emcure Pharma and Sanofi India announced that they entered into an exclusive distribution and promotion agreement for the latter's oral anti-diabetic products in India, effective immediately.

Emcure will exclusively distribute and promote the range of products, which include brands like Amaryl and Cetapin.